Search research articles
Contact Us
Filters
Showing results (11-20 of 133) with videos related to
Page
of 14
Sort By:
Leukemia Research
|
May 2, 2009
Bispecific immunotoxins
Arthur E Frankel, Jung Hee Woo
Leukemia Research
|
December 2, 2006
Advances in AML immunotherapy: the case for T-bodies
Dick Y Suh, Arthur E Frankel
Leukemia Research
|
July 26, 2005
CLL immunotoxins
Arthur E Frankel, Robert J Kreitman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein
Jacqueline Thorburn, Arthur E Frankel, Andrew Thorburn
Autophagy
|
December 23, 2008
Regulation of HMGB1 release by autophagy
Jacqueline Thorburn, Arthur E Frankel, Andrew Thorburn
Plos One
|
December 17, 2008
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Henrick Horita, Arthur E Frankel, Andrew Thorburn
Blood
|
August 3, 2006
Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice
Leman Yalcintepe, Arthur E Frankel, Donna E Hogge
Cancer Discovery
|
September 3, 2016
Developing EZH2-Targeted Therapy for Lung Cancer
Arthur E Frankel, Xin Liu, John D Minna
Cancer Immunology, Immunotherapy : CII
|
April 29, 2006
Fresh frozen plasma and platelet concentrates may increase plasma anti-diphtheria toxin IgG concentrations: Implications for diphtheria fusion protein therapy
Philip D Hall, Debajyoti Sinha, Arthur E Frankel
Expert Opinion on Biological Therapy
|
October 2, 2003
Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells
Girish Mishra, Tie Fu Liu, Arthur E Frankel
Page
of 14
Search research articles
Search
Showing results (11-20 of 133) with videos related to
Sort By:
Page
of 14
Leukemia Research
|
May 2, 2009
Bispecific immunotoxins
Arthur E Frankel, Jung Hee Woo
Leukemia Research
|
December 2, 2006
Advances in AML immunotherapy: the case for T-bodies
Dick Y Suh, Arthur E Frankel
Leukemia Research
|
July 26, 2005
CLL immunotoxins
Arthur E Frankel, Robert J Kreitman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein
Jacqueline Thorburn, Arthur E Frankel, Andrew Thorburn
Autophagy
|
December 23, 2008
Regulation of HMGB1 release by autophagy
Jacqueline Thorburn, Arthur E Frankel, Andrew Thorburn
Plos One
|
December 17, 2008
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Henrick Horita, Arthur E Frankel, Andrew Thorburn
Blood
|
August 3, 2006
Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice
Leman Yalcintepe, Arthur E Frankel, Donna E Hogge
Cancer Discovery
|
September 3, 2016
Developing EZH2-Targeted Therapy for Lung Cancer
Arthur E Frankel, Xin Liu, John D Minna
Cancer Immunology, Immunotherapy : CII
|
April 29, 2006
Fresh frozen plasma and platelet concentrates may increase plasma anti-diphtheria toxin IgG concentrations: Implications for diphtheria fusion protein therapy
Philip D Hall, Debajyoti Sinha, Arthur E Frankel
Expert Opinion on Biological Therapy
|
October 2, 2003
Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells
Girish Mishra, Tie Fu Liu, Arthur E Frankel
Page
of 14